ODDB.org: Open Drug Database

Home - 66766 - 03 - 003

Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung -

Swissmedic Key	66766003	Registration Holder
Name	Irinotecan Accord 300 mg/15 ml, Konzentrat zur Herstellung einer Infusionslösung	Date of registration	24.09.2018
Original/Generic	Generic	Introduction of Sequence	24.09.2018
ATC-Classification	Irinotecan (L01XX19)	Revision date
WHO	WHO-DDD	Valid until	23.09.2023
Index Therapeuticus (BSV)	07.16.10.	Show package size
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication	Zytostatikum
Information for professionals	IP	Consumer information
Ex-factory-Price	294.85	Limitation	No

Deductible	10 %	Consumer price	354.90
Feedback	FB
GTIN	7680667660033	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

irinotecani hydrochloridum trihydricum 300 mg, acidum lacticum, sorbitolum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabilia q.s. ad solutionem pro 15 ml.

Packungsbestandteile

Galenic Form

Konzentrat zur Herstellung einer Injektionslösung

Excipiens

Aqua Ad Iniectabilia Q.s. Ad Solutionem

Active Agent	Dose
Irinotecan Hydrochloride Trihydrate	300mg / 15ml

Inactive agents
Acidum Hydrochloridum
Lactic Acid
Sodium Hydroxide
Sorbitol

Source

Data was imported : 05.12.2018
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :

2019	©ywesee GmbH